| Date Filed | Type | Description |
| 06/30/2023 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 4,602 shares
@ $88.93, valued at
$409.3k
Paid exercise price by delivering 576 shares
@ $88.93, valued at
$51.2k
|
|
| 03/17/2023 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 9,630 shares
@ $0
Paid exercise price by delivering 2,708 shares
@ $87.74, valued at
$237.6k
Paid exercise price by delivering 3,973 shares
@ $93.41, valued at
$371.1k
Granted 21,970 options to buy
@ $87.74, valued at
$1.9M
|
|
| 03/02/2023 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 12,660 shares
@ $0
Granted 10,980 shares
@ $0
Granted 1,250 shares
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,500 shares
@ $107.5, valued at
$268.8k
Exercised 2,500 options to buy
@ $63.1, valued at
$157.8k
|
|
| 12/06/2022 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 1,101 shares
@ $104.5, valued at
$115.1k
Sold 2,139 shares
@ $104.5, valued at
$223.5k
Sold 3,761 shares
@ $104.5, valued at
$393k
Exercised 2,139 options to buy
@ $67.81, valued at
$145k
Exercised 3,761 options to buy
@ $67.81, valued at
$255k
|
|
| 11/28/2022 |
4
| Mueller Brian (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 934 shares
@ $95.09, valued at
$88.8k
Sold 945 shares
@ $99.5, valued at
$94k
Sold 3,500 shares
@ $99.5, valued at
$348.3k
Exercised 3,500 options to buy
@ $67.81, valued at
$237.3k
|
|
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2020 |
4
| Mueller Brian (SVP, Acting CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 414 shares
@ $73.05, valued at
$30.2k
|
|
| 03/17/2020 |
4
| Mueller Brian (SVP, Acting CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 1,303 shares
@ $84.5, valued at
$110.1k
Granted 6,730 shares
@ $0
Granted 9,600 options to buy
@ $73.82, valued at
$708.7k
|
|
| 02/04/2020 |
4
| Mueller Brian (SVP, Acting CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 9 shares
@ $62.229, valued at
$560.1
Granted 5,800 shares
@ $0 |
|
| 06/07/2019 |
4
| Mueller Brian (SVP, Finance and CAO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 299 shares
@ $68.782, valued at
$20.6k
|
|
| 04/09/2019 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,953 shares
@ $94, valued at
$277.6k
|
|
| 03/26/2019 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 415 shares
@ $88.05, valued at
$36.5k
|
|
| 03/19/2019 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 1,149 shares
@ $94.53, valued at
$108.6k
Granted 5,780 shares
@ $0
Granted 9,650 options to buy
@ $94.53, valued at
$912.2k
|
|
| 12/20/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 22 shares
@ $68.782, valued at
$1.5k
|
|
| 06/26/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 654 shares
@ $99.5, valued at
$65.1k
Sold 2,491 shares
@ $99.5, valued at
$247.9k
Exercised 2,491 options to buy
@ $28.23, valued at
$70.3k
|
|
| 06/18/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,021 shares
@ $94.5, valued at
$191k
|
|
| 06/06/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 346 shares
@ $92.07, valued at
$31.9k
|
|
| 03/26/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 414 shares
@ $81.36, valued at
$33.7k
|
|
| 03/20/2018 |
4
| Mueller Brian (SVP, Corporate Controller) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 309 shares
@ $83.57, valued at
$25.8k
Paid exercise price by delivering 346 shares
@ $84.1, valued at
$29.1k
Granted 5,710 shares
@ $0
Granted 9,120 options to buy
@ $83.57, valued at
$762.2k
|
|
| 01/09/2018 |
4
| Mueller Brian (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 84,705 options to buy
@ $1.65, valued at
$139.8k
|
|
|